Current calls, week 6, 2020
Tips from Grants Office about current calls.
Swedish and Nordic calls
Bidrag för cancerforskning - Mary Béves Stiftelse för Barncancerforskning
Stöder forskning och utveckling av barncancervården och utbyte av information mellan forskare. Den totala budgeten uppgår till SEK 850,000.
Closing date: 2 Mars 2020
Erik Rönnbergs stipendier
Välkomna att lämna förslag på kandidater till Erik Rönnbergs treåriga stipendier för vetenskapliga studier av
- Åldrande och åldersrelaterade sjukdomar (2 stipendier). Stipendiebelopp: 300 000 SEK per år och forskare
- Sjukdomar under de tidigare barnaåren (1 stipendium). Stipendiebelopp: 200 000 SEK per år
Stipendierna vänder sig till yngre forskare (upp till 7 år efter disputation) på post-doc-nivå och avser tiden 2021-01-01 – 2023-12-31
Förslagen, med motivering, CV och publikationslista skickas till firstname.lastname@example.org
Closing date: 3 March 2020
Stöd till kliniska forskare – Region Stockholm
Möjliggör forskning på halvtid i kombination med klinisk tjänstgöring om minst 30 procent, i syfte att stärka och förnya den kliniskt inriktade medicinska forskningen. Stöd finns tillgängligt för åtta forskare och uppgår till SEK 500,000 vardera per år i två år.
Closing date: 18 March 2020
Symposia grants – Novo Nordisk Foundation
These support the organisation of symposia which offer leading as well as younger researchers with opportunities to present and discuss the latest research within their fields. Grants are worth up to DKK 150,000 to cover travel, accommodation and prizes.
Closing date: 19 March 2020
Forskningsstipendium – Riksförbundet för Social och Mental Hälsa (RSMH)
RSMH arbetar för att människor med psykisk ohälsa ska ges förutsättningar att komma tillbaka till ett gott liv. Varje år delar RSMH ut ett forskningsstipendium på 40 000 kronor ur stipendiefonden. Enligt fondens stadgar kan stipendium sökas av person som bedriver humanistiskt och socialt inriktad forskning som kan leda till ett bättre liv för människor med psykisk ohälsa. Forskning som sätter brukarens erfarenhet och kunskap i fokus ska särskilt uppmärksammas.
Closing date: 30 March 2020
H2020-JTI-IMI2-2020-20 twentieth call
The Innovative Medicines Initiative Joint Undertaking invites proposals for its twentieth call for proposals. This supports research projects related to the future of medicine within the areas of public health interests. The potential topics for this call are:
•IMI2-2020-20-01 early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis;
•IMI2-2020-20-02 innovations to accelerate vaccine development and manufacture;
•IMI2-2020-20-03 academia and industry united innovation and treatment for tuberculosis;
•IMI2-2020-20-04 tumour plasticity;
•IMI2-2020-20-05 proton versus photon therapy for oesophageal cancer – a trimodality strategy;
•IMI2-2020-20-06 handling of protein drug products and stability concerns.
Proposals may take the form of research and innovation actions, which require participation by at least three legal entities; each established in a different EU member state or Horizon 2020 associated country. Legal entities established in a third country, who secure their own funding, may be included in the consortia.
Total budget: approximately €273.4 million.
Closing date: Stage 1 submissions due by 5pm Brussels time, 21 apr 2020. Stage 2 submissions due by 5 November 2020.
Picchione visiting scholar programme
The Dalhousie Medical Research Foundation invites applications for the Picchione visiting scholar programme. This supports an international scholar in spending time participating in research at Dalhousie University.
Applications should be submitted by the visiting scholar’s sponsor, who must have an appointment in the Faculty of Medicine at Dalhousie University.
Funding is worth up to CAD 3,250 per visit. No minimum or maximum period of stay is required.
Closing date 24 february 2020
Medical and environmental sciences grants
The Sakari Alhopuro Foundation invites applications for its grants. These support research in the fields of medicine, environmental sciences, biodiversity and environmental conservation.
Postdoctoral researchers who have completed their doctoral degree within the last seven years may apply.
Grants are worth up to €60,000 each. Funding is available for personal working grants as well project grants. Grants may also be available for research work abroad or those returning to Finland after a period abroad.
Closing date 29 february 20
Federal Funding agencies
NIBIB Plans to Announce a Prize Competition: NIH Technology Accelerator Challenge: Non-invasive Diagnostic Technologies for Global Health: NIH
The National Institute of Biomedical Imaging and Bioengineering intends to publish a Prize Competition Announcement to solicit entries for the NIH Technology Accelerator Challenge: Non-invasive Diagnostic Technologies for Global Health. The National Institutes of Health (NIH) is supporting the bioengineering competition to spur the design and development of non-invasive, handheld, digital diagnostic devices that will target anemia, sickle cell disease, malaria, and other blood-related diseases.
This Notice is being provided to allow potential entrants sufficient time to form multidisciplinary teams to develop innovative solutions to submit to the competition.
NIBIB intends to award cash prizes for the challenge competition. In addition, the Bill & Melinda Gates Foundation will consider winners and honorable mentions identified through this challenge for potential follow-on support to accelerate development of the proposed device for global health settings.
Closing date: The Announcement is expected to be published February 2020 with an expected submission window from March 2, 2020 through July 2, 2020.
Funding Opportunity Announcement (FOA): RFA-CA-20-007
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional): NIH
This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science.
Closing date: March 6, 2020; November 6, 2020; March 8, 2021 by 5:00 PM local time of applicant organization until March 9, 2021.
Funding Opportunity Announcement (FOA): PAR-18-869
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed): NIH
The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing new tests, animal models, techniques, etc. to advance research on Alzheimer's disease and its related dementias and which need additional preliminary data with broader dissemination to establish them for more general use in this research field. The priority topics will be announced through a series of Notices published subsequent to this FOA.
Closing date: March 11, 2020; July 9, 2020; November 12, 2020; March 11, 2021; July 9, 2021; and November 12, 2021, by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-19-071
FJ McGuigan early career investigator research grant on understanding the human mind (American Psychological Association), US
The F.J. McGuigan Early Career Investigator Research Grant is given biennially to recognize and support the efforts of an early career psychological scientist who is pursuing research that aims to address any aspect of mental function (e.g., cognition, affect, motivation) and seeks to understand the mind from both a behavioral and neural perspective.
Closing date: March 1, 2020
Venture philanthropy programme (Muscular Dystrophy Association), US
The Muscular Dystrophy Association invites applications for its venture philanthropy programme. This supports the discovery and clinical application of treatments and cures for neuromuscular diseases. Projects from proof-of-principle studies through phase 2 trials are eligible.
Biotechnology, pharmaceutical or other companies may apply. Academic projects that fit within the mission of MDA’s translational research programme, whereby the project has a path toward clinical development, are also eligible. Companies may be public or private. Both US and international projects are eligible. For-profit entities are required to contribute funds that match or exceed MDA’s contribution.
The award period is two years or less on average. Funding is worth up to USD 300,000 for research and development projects, up to USD 500,000 for preclinical projects and up to USD 1 million for early clinical projects.
Closing date: March 1, 2020 (LOI).
Neuroendocrine Tumor Research Foundation (NETRF), US
The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for neuroendocrine cancers.
Accelerator Award (AA) proposals ($1,200,000, four years) are the largest NETRF grants in terms of scope, length, and money. These proposals have usually three substantial aims that describe work requiring four years to complete. They might have several collaborators and are often multi-disciplinary or multi-institutional. They can be considered equivalent to an NIH RO1 grant.
Investigator Award (IA) proposal ($300,000, two years) are our medium-size grants. These proposals have usually two (or three smaller) aims that describe work requiring two years to complete. They might have only one PI with or without collaborators. They can be considered equivalent to an NIH R21 grant.
Pilot Award (PA) proposals ($100,000, one year) are the smallest size grants we award. These proposals have usually one (or two smaller) aims that describe work requiring one year to complete. They might have only one PI with or without collaborators. They are usually a proof-of-concept, pilot & feasibility type grant.
Mentor Award (MA) proposals (120,000 over two years) are designed to encourage early career investigators to pursue neuroendocrine tumor research and make a commitment to the field.
Key dates: March 9, 2020 (LOI), June, 2020 (Notification to Submit the Full Application), August, 2020 (Full Proposal)
Research Grants (International OCD Foundation), US
The International OCD Foundation invites applications for its research grants. These support investigators whose research focuses on the nature, causes, and treatment of obsessive-compulsive disorder and related disorders. The following grants are available:
•young investigator awards – worth up to USD 50,000 each over one year, for projects aimed at understanding the causes and treatment for OCD, paediatric OCD, paediatric acute-onset neuropsychiatric syndrome or paediatric autoimmune neuropsychiatric disorder associated with streptococcal infections, body dysmorphic disorder, hoarding disorder or body focused repetitive behaviours. Applicants must be current graduate students or have completed their residency or PhD on or after 1 September 2015.
•breakthrough awards – worth USD 500,000 for three years, for high-risk, high-reward research that focuses on prevention or treatment of OCD. Applicants must have completed their residency or PhD before 1 September 2015 and have at least five years of research experience.
Closing date: March 2, 2020